Download presentation
Presentation is loading. Please wait.
Published byEmily Cox Modified over 8 years ago
2
Monocytes in Immune Defense & Cell-mediated Cytotoxicity Pin Ling ( 凌 斌 ), Ph.D. ext 5632; lingpin@mail.ncku.edu.tw References: 1. Male D., J. Brostoff, D. B Roth, and I. Roitt Immunology (7th ed., 2006), Chapters 9 & 10
3
Question What happens to the immune system if RAG1 or RAG2 is mutated? 1.Severe Combined Immunodeficiency Disease (SCID) 2. Lacking functional T & B cells
4
Outline Cell-mediated immunity Monocytes/Macrophages in immune defense NK & Cytotoxic T cells in immune defense Summary & Question
5
Humoral vs Cell- mediated immunity 1. Humoral immunity => Molecules in body fluid, e.g. Antibody (Ab) => Key player => B cells => Target extracellular microbes & toxins 2. Cell-mediated immunity => Key player => M Φ, NK, & T cells => regulate other immune cells => Target intracellular microbes, e.g. viruses, bacteria For innate immunity, it also includes Humoral & Cellular components for immune defense
6
Key Concepts in Monocytic Phagocytes in Immune Defense-I 1. Macrophages differentiate from circulating blood monocytes. 2. Macrophages are very heterogeneous in cellular activities, and may play positive or negative roles in immune defense and tissue homeostasis. 3. Tissue (Resident) & recruited macrophages respond to injury and immune stimuli. 4. Cytokines, Chemokines, & environmental stimuli modulate the phenotype of macrophages.
7
Maturation of Macrophages Activated Macro
8
Differentiation of Monocytes Tissue MΦ Localized M Φ Regulated by environmental stimuli
9
Different types of tissue macrophages
10
Roles of macrophages & DCs in immune defense
11
Cytokines modulate the phenotype of macrophages-I
12
Cytokines/environmental stimuli on macrophages
13
Granuloma in pulmonary tuberculosis
14
Cytokines modulate the phenotype of macrophages-II
15
Th1 & Th2 cytokines act on macrophages
16
Key Concepts in Monocytic Phagocytes in Immune Defense-II 1. Macrophages use phagocytosis to kill invading pathogens and to clean apoptotic cells. 2. Macrophages express a variety of surface receptors to interact with pathogens, other cells (apoptotic cells), or environment. 3. Opsonic receptors, like Fc (for Ab) & complment receptors, mediate indirect binding (Opsonization) to pathogens. 4. Non-opsonic receptors, like Scavenger & Toll-like receptors, mediate direct binding to pathogenic components (PAMPs).
17
Phagocytosis of bacteria by opsonic receptors on macrophages
19
Fc & complement receptors on macrophages for uptaking bacteria
20
Opsonization Direct binding Recognition of bacteria by Macrophage
21
Scavenger receptors recognize apoptotic cells
22
Lectin-like receptors bind various sugar ligands from pathogens
23
TLR4/MD2 and CD14 complex for LPS recognition
24
TLR-mediated IFN-b activation against viral infection
25
Macrophages have intracellular receptors for detecting pathogens
26
Macrophages produce a variety of secreted molecules
27
ROS-mediated killing bacteria in activated macrophages
28
NOS pathway in activated macrophages
29
Roles of activated macrophages in immunopathology
30
Outline Cell-mediated immunity Monocytes/Macrophages in immune defense NK cells & Cytotoxic T lymphocytes (CTLs) in immune defense Summary & Question
31
Key concepts in NK & CTL in immune defense 1. Cell-mediated cytotoxicity is an essential defense against intracellular pathogens, including viruses, some bacteria and parasites. 2. Cytotoxicity is regulated by celluar interactions, cytokines, and granule exocytosis. 3. CTLs recognize their target cells presenting Ag on MHC-I. NK cells are activated once their target cells lost MHC-I. 4. Tumor cells may also become the targets of cytotoxic cells
32
Recognition of target cells by CTLs and NK cells
33
Interactions between CTLs and target cells
34
Effector functions of CTLs and CD4+ T helper cells
35
Granule exocytosis of CTLs-I
36
Granule exocytosis of CTLs-II
37
Figure 8-35
38
CTLs induce apoptosis in target cells
39
Ligation of Fas (CD95) or TNFR triggers apoptosis in target cells
40
Figure 2-49
41
Activation of NK cells once target cells lost MHC-I 1.Virus-infected cells & tumor cells tend to lost MHC-I to avoid CTL attack. 2.NK cells are complementary to CTLs for immune defense.
42
NK cells express a variety of inhibitory & activating receptors CD94-NKG2A CD94-NKG2C
43
HLA-E presents peptides of MHC-I to NK cells
44
Killer immunoglobulin-like receptors (KIRs)
45
Ab-dependent cell-mediated cytotoxicity (ADCC) by NK cells
46
SUMMARY 1.Macrophages are key players in innate immunity and also link to adaptive immunity. 2. Macrophages use phagocytosis to kill invading pathogens and to clean apoptotic cells. 3.NK cells also play a key role in innate immunity and function complementary to CTLs against viruses and tumors. 4. Cell-mediated cytotoxicity is an essential defense against intracellular pathogens, including viruses, some bacteria and parasites.
48
Downloaded from: StudentConsult (on 30 August 2006 04:38 AM) © 2005 Elsevier
49
Downloaded from: StudentConsult (on 30 August 2006 04:38 AM) © 2005 Elsevier
50
Downloaded from: StudentConsult (on 30 August 2006 04:38 AM) © 2005 Elsevier
51
Downloaded from: StudentConsult (on 30 August 2006 04:38 AM) © 2005 Elsevier
52
Downloaded from: StudentConsult (on 30 August 2006 04:38 AM) © 2005 Elsevier
53
Downloaded from: StudentConsult (on 30 August 2006 04:38 AM) © 2005 Elsevier
54
Downloaded from: StudentConsult (on 30 August 2006 04:38 AM) © 2005 Elsevier
55
Downloaded from: StudentConsult (on 30 August 2006 04:38 AM) © 2005 Elsevier
56
Downloaded from: StudentConsult (on 30 August 2006 04:38 AM) © 2005 Elsevier
57
Downloaded from: StudentConsult (on 30 August 2006 04:38 AM) © 2005 Elsevier
58
Downloaded from: StudentConsult (on 30 August 2006 04:39 AM) © 2005 Elsevier
59
Downloaded from: StudentConsult (on 30 August 2006 04:39 AM) © 2005 Elsevier
60
Downloaded from: StudentConsult (on 30 August 2006 04:39 AM) © 2005 Elsevier
61
Granuloma in pulmonary tuberculosis
62
Figure 8-27
63
Downloaded from: StudentConsult (on 30 August 2006 04:39 AM) © 2005 Elsevier
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.